MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0068466
Nexzen Formulations Limited
Nexzen Formulations Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.54 Cr
▼ 11% YoY
Net profit · FY 2025
₹52,605
Net margin 0.3%
EBITDA · FY 2025
₹7.21 Lakh
EBITDA margin 4.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹49 Lakh
Secured borrowings
Company age
18 yrs
Est. 2008
Employees · EPFO
15
Provident fund records
About Nexzen Formulations Limited
Data last updated:
Nexzen Formulations Limited is a public limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 June 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2008PLC068133. Its GSTIN is 33AADCN0600P1ZO (Tamil Nadu).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Nexzen Formulations Private Limited. It is led by directors including Kirankumar Venkata Sathyasai Boggarapu and Venkatasatyananda Koteswara Rao Boggarapu.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 67/2 3rd Street Railway Colony Nmm Road, Chennai, Tamil Nadu, India – 600029.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.54 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹52,605 (net margin 0.3%) and EBITDA of ₹7.21 Lakh (EBITDA margin 4.7%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹49 Lakh on record.
Nexzen Formulations Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0068466). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230TN2008PLC068133
Registration Number 068133
Incorporation Date 11 June 2008
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0068466
CIN history
Nexzen Formulations has one previous CIN (Corporate Identification Number): U24230TN2008PTC068133. The current CIN is U24230TN2008PLC068133, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TN2008PLC068133 | Current |
| U24230TN2008PTC068133 | Previous |
Key People
Kirankumar Venkata Sathyasai Boggarapu Director Venkatasatyananda Koteswara Rao Boggarapu Director Malini Cheedella Director Recognitions & Rankings of Nexzen Formulations
Contact details
Nexzen Formulations Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address67/2 3rd Street Railway Colony Nmm Road, Chennai, Tamil Nadu, India – 600029
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nexzen Formulations Limited, buy the company report.
Comprehensive company report
Nexzen Formulations Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nexzen Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nexzen Formulations Limited, buy the company report.
Financials of Nexzen Formulations Limited
FY 2025 filings availableNexzen Formulations Limited reported revenue of ₹1.54 Cr (down 11% YoY) for FY 2025.
Revenue · FY 2025
₹1.54 Cr ▼ 11%
Net profit · FY 2025
₹52,605 margin 0.3%
EBITDA · FY 2025
₹7.21 Lakh margin 4.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 2%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 54%
3 years · compounded
▲ 13%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 11% fall in the latest year. EBITDA fell 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.21 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52,605 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nexzen Formulations Limited, buy the company report.
Board of directors of Nexzen Formulations Limited
Nexzen Formulations has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kirankumar Venkata Sathyasai Boggarapu Also directs: Ozabio Private Limited | Director | 11 Jun 2008 | 18 Years 5 Months | Current |
| Venkatasatyananda Koteswara Rao Boggarapu | Director | 09 Mar 2009 | 17 Years 8 Months | Current |
| Malini Cheedella Also directs: Ozabio Private Limited | Director | 11 Jun 2008 | 18 Years 5 Months | Current |
Shareholding
The shareholding of Nexzen Formulations Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Nexzen Formulations Limited, buy the company report.
Charges & borrowings
Open charges
₹49 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jan 2015 | 10551539 | Andhra Bank | ₹49 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Nexzen Formulations Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nexzen Formulations Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nexzen Formulations Limited has a workforce of 15 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
15
Active EPFO establishments
1
Employee growth
7.1%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 15 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Nexzen Formulations Limited, buy the company report.
GST
Nexzen Formulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AADCN0600P1ZO | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nexzen Formulations Limited, buy the company report.
Recent activity
Nexzen Formulations Limited has 3 board changes on record since 2008: 3 appointments. The latest: Venkatasatyananda Koteswara Rao Boggarapu was appointed as Director on 09 Mar 2009.
AGM
Nexzen Formulations Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Nexzen Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Andhra Bank amounted to Rs. 0.49 Cr with Charge ID 10551539 was registered on 03 Jan 2015.
Appointed
Venkatasatyananda Koteswara Rao Boggarapu was appointed as Director.
Appointed
Kirankumar Venkata Sathyasai Boggarapu was appointed as Director.
Appointed
Malini Cheedella was appointed as Director.
Incorporation
11 Jun 2008
Nexzen Formulations Limited was registered on 11 Jun 2008 with Roc Chennai & aged 18 years 5 months as per MCA records.
Frequently asked questions
Nexzen Formulations is an active public limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 June 2008 (18+ years old) and is registered under CIN U24230TN2008PLC068133.
Nexzen Formulations has 3 current directors:
- Kirankumar Venkata Sathyasai Boggarapu - Director
- Venkatasatyananda Koteswara Rao Boggarapu - Director
- Malini Cheedella - Director
The latest financial statements of Nexzen Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nexzen Formulations is 33AADCN0600P1ZO, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Nexzen Formulations is U24230TN2008PLC068133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexzen Formulations was incorporated on 11 June 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chennai.
Venkatasatyananda Koteswara Rao Boggarapu was appointed as Director on 09 Mar 2009. Kirankumar Venkata Sathyasai Boggarapu was appointed as Director on 11 Jun 2008. Malini Cheedella was appointed as Director on 11 Jun 2008.
Yes, Nexzen Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0068466).
The registered office of Nexzen Formulations is at 672 3rd Street Railway Colony Nmm Road, Chennai, Tamil Nadu, India – 600029.
Nexzen Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages